EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Familial melanoma: genetic, clinical, and dermoscopic insights and follow-up

Alise Emma Raika, Maria Elena de Las Heras Alonso, Diana Sproge, Elga Bataraga

Frontiers in Medicine · 27.07.2026 · 13

DOI: 10.3389/fmed.2026.1906952 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Medicine, online erschienen am 27.07.2026. Verfasst von Alise Emma Raika und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Riga Stradins University, Riga, Latvia. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Familial melanoma accounts for approximately 5–10% of all melanoma cases. It is characterized by an earlier age of onset. Multiple primary melanomas occur in up to a fifth of patients with a positive family history, compared to 5% in sporadic cases. Pathologically, familial melanomas tend to present at thinner Breslow depths and show a higher proportion of in situ lesions compared to their sporadic counterparts, with a predilection for the lower limbs. The genetic landscape of familial melanoma is heterogeneous. CDKN2A and CDK4 mutations act through UV-dependent and cell cycle disruption pathways, while BAP1, POT1, and TERT mutations are considered UV-independent. Beyond cutaneous melanoma, germline mutations confer an increased risk for additional malignancies, including pancreatic cancer, renal cell carcinoma, mesothelioma, and neural system tumors, necessitating multidisciplinary surveillance and genetic counseling for affected families. Dermoscopically, CDKN2A mutation carriers predominantly present with superficial spreading melanoma, displaying atypical pigment networks, irregular dots and globules, regression structures, and a blue-white veil. Co-occurrence of MC1R variants may produce more subtle, structureless presentations with a lower total dermoscopy score, posing additional diagnostic challenges. Sequential digital dermoscopy and total body photography remain the cornerstones of surveillance, with follow-up every 3–6 months recommended for mutation carriers. All patients should receive structured education on photoprotection, including the use of broad-spectrum SPF50+ sunscreen and sun avoidance measures.

Schlagwörter

Stichwörter der Autor:innen

BAP1CDKN2Adermoscopyfamilial melanomamultiple primary melanomas

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, Riga Stradins University, Riga, Latvia.
  • University Hospital Ramón y Cajal, Madrid, Spain.
  • Department of Medicine, University of Alcalá, Madrid, Spain.

Zitieren

APA

Raika, A. E., de Las Heras Alonso, M. E., Sproge, D., & Bataraga, E. (2026). Familial melanoma: genetic, clinical, and dermoscopic insights and follow-up. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1906952

Vancouver

Raika AE, de Las Heras Alonso ME, Sproge D, Bataraga E. Familial melanoma: genetic, clinical, and dermoscopic insights and follow-up. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1906952

BibTeX
@article{Raika2026,
  author = {Raika, Alise Emma and de Las Heras Alonso, Maria Elena and Sproge, Diana and Bataraga, Elga},
  title = {Familial melanoma: genetic, clinical, and dermoscopic insights and follow-up},
  journal = {Frontiers in Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fmed.2026.1906952}
}
Kostenlos starten →